insights_auto
Outlook: 66.7% bullish·3.0% bearish
Go to analysischevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,46 $
arrow_downward
-1,36%(-0,020) 1D
12 қар., 10:58:17 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,44 $
High
1,47 $
Low
1,33 $
Mkt. cap
272,54 млн
Avg. vol.
19,06 млн
Volume
1,93 млн
52-wk high
2,72 $
52-wk low
0,56 $
EPS
-1,17 $
Beta
1,71
Shares outstanding
187,31 млн
No. of employees
112
Open
1,44 $
High
1,47 $
Low
1,33 $
Mkt. cap
272,54 млн
Avg. vol.
19,06 млн
Volume
1,93 млн
52-wk high
2,72 $
52-wk low
0,56 $
EPS
-1,17 $
Beta
1,71
Shares outstanding
187,31 млн
No. of employees
112
News stories
From web sources and news partners
Yahoo Finance
·
4 сағат бұрын
Inovio Pharmaceuticals Inc (INO) (Q3 2026) Earnings Call Highlights: FDA Approval, Commercial ...
GuruFocus
·
1 күн бұрын
INO Reiterated by Piper Sandler -- Price Target Lowered to $6.00
Yahoo Finance
·
1 күн бұрын
Inovio Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
Yahoo Finance
·
1 күн бұрын
Inovio Pharmaceuticals Q3 Earnings Call Highlights
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc